All estimated odds ratio (OR) and 95% confidence interval (CI) were adjusted by the baseline age, BMI, Ki67, P53, stage, HER2, ER, PR, lymphatic metastasis, hypertension and menopause status. The gene discussed is ERBB2; the disease is Lymphatic Metastasis.